Mark Brosius, the Executive Vice President and Chief Manufacturing and Supply Chain Officer at Intuitive Surgical, has reported recent stock transactions in a filing with the SEC. This disclosure is significant as it reflects the company's adherence to regulatory requirements and transparency in executive trading activities.

Background

Intuitive Surgical Inc., identified by CIK 0001035267, operates in the orthopedic, prosthetic, and surgical appliances and supplies sector. The company is incorporated in Delaware and has its fiscal year ending on December 31. Recent filings show that Brosius has been actively managing his stock holdings, with multiple transactions reported in the past few months.

What the Filing Says

The filing, dated November 2, 2026, reveals that Brosius sold 61 shares of Intuitive Surgical common stock on October 29, 2026, at a price of $447.85 per share. The following day, he sold an additional 63 shares at $453.60 per share. After these transactions, Brosius retains ownership of 457 shares.

The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.

Impact

This update may affect stakeholders including investors and analysts monitoring executive actions within Intuitive Surgical. The transparency demonstrated by Brosius's filings may influence perceptions of corporate governance and executive accountability within the orthopedic and surgical appliance industry.

What's Next

The filing does not say what happens next.